Differences in Drug Shortages in the US and Canada
Drug-related reports of supply chain issues were 40% less likely to result in meaningful drug shortages in Canada compared with the US. These findings highlight the need for international cooperation between countries to curb the effects of drug shortages and improve resiliency of the supply chain for drugs.
Authors
- Katie J. Suda
- Inmaculada Hernandez (ORCID: https://orcid.org/0000-0002-0118-4986)
- Walid F. Gellad (ORCID: https://orcid.org/0000-0002-6992-5197)
- Tina Batra Hershey (ORCID: https://orcid.org/0000-0002-8600-6168)
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Lisa M. Maillart (ORCID: https://orcid.org/0000-0002-6321-2671)
- Scott D. Rothenberger
- Joshua W. Devine (ORCID: https://orcid.org/0009-0004-1508-3846)
- Katherine Callaway Kim (ORCID: https://orcid.org/0000-0002-2924-6165)
Institutions
- University of Pittsburgh (US)
- University of Toronto (CA)
- University of California San Diego (US)
- VA Pittsburgh Healthcare System (US)
- Des Moines University (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1001/jama.2024.17688
- Citations
- 16
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 18.07